Kimberly M. Padilla, APRN

Kimberly Padilla practices at Renown Regional Medical Center in Reno, Nevada, part of Renown Health.

Kimberly Padilla's NPI, 1376131284, was assigned on January 6, 2021. Kimberly Padilla holds Nevada license 837833.

Kimberly Padilla's primary practice is Renown Regional Medical Center, at 1155 Mill Street, Reno, NV 89502 in Washoe County. The practice phone is (775) 982-4100.

Kimberly Padilla's primary practice is Renown Regional Medical Center in Reno, Nevada, part of Renown Health. Kimberly Padilla is also affiliated with Banner Churchill Community Hospital. The medical group on file is Renown Health. Dmand AI also links Kimberly Padilla to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kimberly Padilla practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Kimberly Padilla's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Kimberly Padilla is licensed in Nevada.

Dmand AI lists acute sinusitis, acute skin infection, adjustment disease, anxiety, bronchitis, bursitis, chest wall injury and chronic diabetes among the conditions Kimberly Padilla treats.

CMS data shows 660 Medicare services from Kimberly Padilla across 8 procedure codes in 2024, for 403 Medicare patients. Medicare paid $34,486 for them. Every service was in an office.

CMS counts 403 Medicare patients who saw Kimberly Padilla in 2024. The largest group is 65 to 74, with 196 patients. 71% of them have high cholesterol, and 65% have high blood pressure. 9% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Kimberly Padilla's median patient age at 43, with 67% women.

In 2024, Kimberly Padilla wrote 440 Medicare Part D claims for 231 patients. 88% of them were for generic drugs. CMS names the drug for 206 of them, across 9 drugs with 11 or more claims each, at $2,031 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Kimberly Padilla for performance year 2024, reported as part of a group. Kimberly Padilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Kimberly Padilla from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $149.